MoneyWorks4Me

Natco Pharma to consider Interim Dividend

30 Jan 2012 Evaluate

Natco Pharma has informed that a meeting of the board of directors of the company will be held on February 09, 2012, to consider the unaudited financial results for the quarter ended December 31, 2011, to consider Interim Dividend, if any, for the financial year 2011-12 and related matters.

The above information is part of company’s filing submitted to the BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..